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tant cause of morbidity and mortality, particularly in children 
and the elderly. According to the World Health Organization, 
pneumonia is the major cause of death in children, account-
ing for 16% of all deaths in children under 5 years of age in 
20151. In the United States, pneumonia is the sixth most com-
mon cause of death. Two to three million cases of CAP per 
year resulted in 10 million visits to a physician, 500,000 hospi-
talizations, and 45,000 deaths2.
In Korea, pneumonia is the fifth ranked cause of death, 
with a mortality rate of 23.7/100,000 person years (PY) in 
20143. Moreover, the mortality rate was 74 times higher 
(177.5/100,000 PY) in patients older than 65 years of age 
compared to those younger than 65 years (2.4/100,000 PY). 
As the aged population increases, the number of patients 
treated for pneumonia is also increasing along with a rapid 
rise in medical costs in Korea. Assessing the quality of care for 
patients with pneumonia is necessary because quality mea-
sure is related to patient outcomes. Assessment of pneumonia 
severity using oxygenation assessment, Pneumonia Severity 
Index (PSI) and CURB-65 enable the clinicians to initiate early 
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common diseases worldwide. Pneumonia is also an impor-
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and appropriate treatment including oxygen therapy4. Micro-
biologic testing is required because it can lead to a change in 
antibiotics therapy in up to 40% of patients with severe pneu-
monia5. Timely antibiotics administration is associated with 
lower risk of mortality6-8. Smoking cessation and pneumococ-
cal vaccination are effective in preventing pneumonia9-11. The 
Health Insurance Review and Assessment Service (HIRA, 
Seoul, Korea), a government-affiliated agency that examines 
the accuracy of claims for National Health Insurance and 
National Medical Aid, evaluates the nationwide care status of 
hospitalized adult patients with CAP to assess and improve 
the quality of diagnosis and the treatment of pneumonia. This 
is the first study to report hospital performance for hospital-
ized patients with CAP in Korea. The aim of this evaluation 
was to assess the overall quality of care provided for hospital-
ized adult patients with CAP, and to use the quality measure 
as the basis for evaluating the treatment outcome of CAP.
Materials and Methods
1. Study institutions 
HIRA comprehensively analyzed the medical records of 
hospitalized adult patients with CAP from all of the health 
institutions that claimed five or more cases of hospitalization 
with CAP (except for nursing homes) from October to De-
cember 2014. HIRA classified the health institutions into three 
categories: hospital, general hospital, and tertiary hospital. A 
hospital is a medical facility with more than 30 beds where 
doctors, dentists, and oriental medical doctors perform medi-
cal treatments for hospitalized patients. A general hospital 
is a hospital with more than 100 beds. The following criteria 
should be met when defining a general hospital. In the case 
of 100 beds or more and less than 300 beds, there should be 
more than seven medical departments including Radiology, 
Anesthesiology, and Laboratory Medicine (Pathology as an 
alternative) and at least three medical courses of the follow-
ing: Internal Medicine, Surgery, Pediatric Adolescents, and 
Obstetrics and Gynecology. Specialists should be assigned to 
each medical department. If there are more than 300 beds, 
there should be more than nine medical departments includ-
ing Internal Medicine, Surgery, Pediatric Adolescents, Obstet-
rics and Gynecology, Radiology, Anesthesiology, Laboratory 
Medicine (Pathology as an alternative), Psychiatry, and Den-
tistry. Again, specialists should be assigned to each medical 
department. A tertiary hospital is a general hospital that has 
specialists assigned to more than 20 medical departments 
and is equipped with the manpower, facilities, and equipment 
prescribed by the Ordinance of the Ministry of Health and 
Welfare.
2. Study subjects
The study subjects comprised hospitalized adult patients 
aged 18 years or more with CAP and treated with intrave-
nous antibiotics for a period of 3 days or more. Subjects were 
excluded if they had the following conditions: patients with 
hospital-acquired pneumonia, ventilator-associated pneu-
monia, postoperative pneumonia, or healthcare-associated 
pneumonia; patients whose treatment for pneumonia was 
delayed because of other acute illnesses such as emergency 
surgery; patients who were not administered intravenous 
antibiotics within 72 hours after hospitalization; patients who 
were transferred to the hospital after the initiation of intra-
venous antibiotics; patients who had a history of 2 or more 
days of hospitalization within a 90-day period; patients who 
were treated in a nursing home; patients receiving palliative 
care or hospice care; patients who had been diagnosed with 
malignant disease or had received anti-cancer therapy includ-
ing chemotherapy and radiation therapy within a period of 3 
months; patients who had an immunocompromised disease 
or received immunosuppressive therapy; patients who had 
been treated with high-dose steroids (20 mg/day for 2 weeks 
or more); patients undergoing dialysis eight times or more per 
month within a 30-day period; and patients with human im-
munodeficiency virus infection.
3. CAP hospital inpatient quality measure set
The hospital inpatient quality measure set for CAP was 
developed by a committee of the Korean Academy of Tuber-
culosis and Respiratory Diseases from June 2013 to February 
2014. 
The committee developed 15 measures consisting of eight 
core measures and five (additional) monitoring measures 
to evaluate the nationwide care status of hospitalized adult 
patients with CAP (Table 1). Measurement of arterial oxygen-
ation (CAP1) is important in the initial evaluation of patients 
with CAP because hypoxemia has been associated with respi-
ratory failure, intensive care unit admission and mortality12-14. 
PSI and CURB65 (CAP2), which are indicators of the severity 
of pneumonia, have been reported to be crucial for selection 
of appropriate location of treatment, initial empirical antimi-
crobial agents15,16. Sputum staining (CAP3), sputum culture 
(CAP4), and blood cultures prior to first intravenous antibiot-
ics administration (CAP5) are recommended as a diagnostic 
method based on guidelines for pneumonia because they can 
be used to set the direction of initial treatment4.
First dose of antibiotic within 8 hours (CAP6), median time 
from initial hospital arrival to first dose of antibiotic (CAP9), 
selection of appropriate initial antibiotics (CAP10), duration 
of intravenous antibiotic administration (CAP11) are recom-
mended based on guidelines for pneumonia8. Timely antibi-
otic affects prognosis and the mortality rates in patients with 
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CAP17,18. Guideline-recommended antibiotics can reduce the 
risk of death from pneumonia up to 30% compared with non-
guideline-recommended antibiotics19. Smoking cessation 
(CAP7) is helpful in preventing pneumonia8,20.
According to guidelines of the Advisory Council on Im-
munization Practices of the Centers for Disease Control and 
Prevention, the major preventive measures for CAP are use 
of pneumococcal vaccines21. Since 2013, pneumococcal vac-
cination (CAP8) has been included in the National Immu-
nization Program for people over 65 years of age in Korea22. 
30-Day readmission rate (CAP12) and 30-day mortality rate 
(CAP13) were included to assess the severity of pneumonia 
based on guidelines for pneumonia8.
4. Composite measure score
HIRA calculated the composite measure score in institu-
tions that claimed 10 or more evaluated cases. The weighted 
value of each core measure was determined by the Pneumo-
nia subcommittee centered on the experts recommended 
by each society according to clinical significance and it was 
finalized by the Medical Assessment Coordinating Commit-
tee (Table 2). The composite measure score was calculated by 
dividing the sum of the weighted core measures by the sum of 
the weighted values of the core measures:
 
Composite measure score= 
∑(Score of the measure×weighted value)
∑Weighted value
Table 1. CAP hospital inpatient quality measure set
Measure Measure name Measure description
Core CAP 1 Oxygenation assessment Oxygenation assessment using either arterial blood gas or pulse 
oxymetry within 24 hours of hospital arrival
CAP 2 Pneumonia severity assessment Assessment of CAP severity using either PSI or CURB-65 within 24 
hours of hospital arrival 
CAP 3 Sputum smears Evaluation of sputum smears within 24 hours of hospital arrival
CAP 4 Sputum cultures Evaluation of sputum cultures within 24 hours of hospital arrival
CAP 5 Blood cultures prior to first intravenous 
antibiotics administration
Proportion of blood cultures obtained prior to first intravenous anti-
biotics administration of all blood cultures*
CAP 6 First dose of antibiotic within 8 hours Proportion of administration of first dose of antibiotic within 8 hours 
of hospital arrival
CAP 7 Smoking cessation advice/counseling Smoking cessation advice/counseling given to patients who have 
smoked within 1 year
CAP 8 Screening for pneumococcal vaccination Screening for pneumococcal vaccination among patients 65 years of 
age and older
Monitoring CAP 9 Median time from initial hospital arrival to 
first dose of antibiotic
Median time from initial hospital arrival to first dose of antibiotic
CAP 10 Selection of appropriate initial antibiotics Initial antibiotic selection consistent with current recommendation
CAP 11 Duration of intravenous antibiotic adminis-
tration
Duration of intravenous antibiotic administration
CAP 12 30-Day readmission rate Readmission with CAP within 30 days after initial discharge
CAP 13 30-Day mortality rate Mortality within 30 days after hospitalization
*Denominator consists of hospitalized CAP patients who have had a blood culture.
CAP: community-acquired pneumonia; PSI: Pneumonia Severity Index.
Table 2. Weighted value of core measure
Measure Measure name
Weighted 
value
CAP 1 Oxygenation assessment 2
CAP 2 Pneumonia severity assessment 2
CAP 3 Sputum smears 0.5
CAP 4 Sputum cultures 0.5
CAP 5 Blood cultures prior to first intravenous 
antibiotics administration
1.5
CAP 6 First dose of antibiotic within 8 hours 2
CAP 7 Smoking cessation advice/counseling 1
CAP 8 Screening for pneumococcal vaccination 0.5
CAP: community-acquired pneumonia.
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Results
1. Characteristics of the medical institutions and hospi-
talization cases
The analysis included data from 523 hospitals (42 tertiary 
hospitals [8.0%], 256 general hospitals [49%], and 225 hospitals 
[43.0%]). There were 15,432 evaluated cases (tertiary hospi-
tals, 1,673 cases [10.8%]; general hospitals, 8,803 cases [57.1%]; 
hospitals, 4,956 cases [32.1%]). The estimated total medical 
cost was 31.8 billion won/28.5 million US dollars (USD) (ter-
tiary hospitals, 5.1 billion won/4.5 million USD [16.0%]; gen-
eral hospitals, 19.8 billion won/17.8 million USD [62.2%]; and 
hospitals, 6.9 billion won/6.2 million USD [21.8%]). Table 3 
shows the admission route and regional distribution of cases. 
The most frequent admission routes were hospitalization on 
a general ward via the outpatient department (9,542 [61.8%]), 
followed by admission to a general ward via the emergency 
room (4,473 [29%]), and admission to the intensive care unit 
via the emergency room (1,166 [7.6%]). Gyeonggi-do was the 
highest ranked region (16.7%), followed by Seoul (11.7%) and 
Gyeongsangnam-do (10.9%).
2. Participant demographics
Table 4 provides an overview of the participant demo-
graphics. More women were enrolled than men (8,062 cases 
[52.2%]). Study subjects older than 70 years of age accounted 
for 50% (7,449) of cases, those aged 70–79 years accounted for 
24.2% (3,731) of cases, and subjects older than 80 years of age 
Table 3. The admission routes and regional distribution
 Total Tertiary hospital General hospital Hospital
Total 15,432 (100) 1,673 (10.8) 8,803 (57.1) 4,956 (32.1)
Admission route
   Outpatient
      GW 9,542 (61.8) 607 (3.9) 5,140 (33.3) 3,795 (24.6)
      ICU 251 (1.6) 10 (0.1) 159 (1.0) 82 (0.5)
   ER
      GW 4,473 (29) 889 (5.8) 2,652 (17.2) 932 (6.0)
      ICU 1,166 (7.6) 167 (1.1) 852 (5.5) 147 (1.0)
Region
   Seoul 1,803 (11.7) 602 (3.9) 980 (6.4) 221 (1.4)
   Busan 961 (6.2) 134 (0.9) 583 (3.8) 244 (1.6)
   Incheon 659 (4.3) 156 (1.0) 450 (2.9) 53 (0.3)
   Daegu 898 (5.8) 177 (1.1) 277 (1.8) 444 (2.9)
   Gwangju 872 (5.7) 46 (0.3) 655 (4.2) 171 (1.1)
   Daejeon 420 (2.7) 43 (0.3) 342 (2.2) 35 (0.2)
   Ulsan 272 (1.8) 23 (0.1) 119 (0.8) 130 (0.8)
   Gyeonggi 2,583 (16.7) 266 (1.7) 1,659 (10.8) 658 (4.3)
   Gangwon 715 (4.6) 26 (0.2) 454 (2.9) 235 (1.5)
   Chungbuk 477 (3.1) 25 (0.2) 305 (2.0) 147 (1.0)
   Chungnam 781 (5.1) 88 (0.6) 370 (2.4) 323 (2.1)
   Jeonbuk 886 (5.7) 31 (0.2) 381 (2.5) 474 (3.1)
   Jeonnam 1,185 (7.7) 0 (0) 620 (4.0) 565 (3.7)
   Gyeongbuk 902 (5.8) 0 (0) 567 (3.7) 335 (2.2)
   Gyeongnam 1,676 (10.9) 56 (0.4) 726 (4.7) 894 (5.8) 
   Jeju 330 (2.1) 0 (0) 315 (2.0) 15 (0.1)
   Sejong 12 (0.1) 0 (0) 0 (0) 12 (0.1)
Values are presented as number (%).
GW: general ward; ICU: intensive care unit; ER: emergency room.
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accounted for 24.1% (3,781) of cases.
3. Hospital CAP core measures
Table 5 shows the performance rates of the hospital CAP 
core measures. Five measures were obtained including 
data related to oxygenation assessment obtained from 523 
institutions (100%), blood cultures taken before the initial 
administration of antibiotics obtained from 336 institutions 
(64.2%), smoking cessation counseling obtained from 138 
institutions (26.4%), and screening for pneumococcal vac-
cination obtained from 469 institutions (89.7%). The variation 
in overall performance rate of the hospital CAP core measures 
was large, ranging from 53.7% to 93.1%. The performance rate 
was higher in terms of the administration of the first antibiotic 
dose within 8 hours from the time of hospital arrival (93.1%), 
smoking cessation counseling (92.2%), and blood cultures 
obtained prior to the first administration of antibiotics (85.2%). 
The performance rate was lower in terms of pneumonia se-
verity assessment (56.3%) and screening for pneumococcal 
vaccination (53.7%).
1) CAP 1. Oxygenation assessment within 24 hours of 
hospital arrival
The overall performance rate of oxygenation assessment 
within 24 hours of arrival at hospital was 68.1%. Oxygenation 
assessment within 24 hours of hospital arrival varied greatly 
depending on the institution (tertiary hospitals, 99.5%; general 
hospitals, 81.9%; hospitals, 33.0%) (Figure 1). The minimum 
rate was 0% and the maximum rate was 100%. Among hospi-
tals, in particular, the performance rate for oxygenation assess-
ment was low with a large variation (mean, 30.6%; Q1, 3.6%; 
Q3, 51.5%) (Figure 1). Fifty-eight institutions had a minimum 
measure rate of zero (3 general hospitals and 55 hospitals).
2) CAP 2. Pneumonia severity assessment
The overall performance rate for pneumonia severity as-
sessment was 56.3%. This greatly varied depending on the 
institution (tertiary hospitals, 98.4%; general hospitals, 72.2%; 
hospitals, 13.8%) (Figure 2). The minimum rate was 0% and 
the maximum rate was 100%, indicating that pneumonia se-
verity assessment is rarely performed in hospitals (Q1, 0%; Q3, 
0%). Even general hospitals showed a large variation in the 
performance rate for pneumonia severity assessment (mean, 
68.9%; Q1, 7.7%; Q3, 100%).
3) CAP 3. Sputum smear within 24 hours of arrival
The overall performance rate of sputum smears performed 
Table 4. The demographics of study participants
Total
Tertiary 
hospital
General 
hospital
Hospital
Total 15,432 (100) 1,673 (10.8) 8,803 (57.1) 4,956 (32.1)
Sex
   Male 7,370 (47.8) 946 (6.1) 4,332 (28.1) 2,092 (13.5)
   Female 8,062 (52.2) 727 (4.7) 4,471 (29.0) 2,864 (18.6)
Age, yr
   18–19 151 (1.0) 15 (0.1) 90 (0.6) 46 (0.3)
   20–29 649 (4.2) 62 (0.4) 390 (2.5) 197 (1.3)
   30–39 1,396 (9.0) 144 (0.9) 852 (5.5) 400 (2.6)
   40–49 1,214 (7.9) 115 (0.7) 731 (4.7) 358 (2.4)
   50–59 2,135 (13.8) 255 (1.7) 1,165 (7.5) 715 (4.6)
   60–69 2,438 (15.8) 319 (2.1) 1,383 (9.0) 736 (4.8)
   70–79 3,731 (24.2) 443 (2.9) 2,140 (13.9) 1,148 (7.4)
   ≥80 3,718 (24.1) 320 (2.1) 2,052 (13.3) 1,346 (8.7)
Values are presented as number (%).
Table 5. The performance of hospital CAP core measures
Measure name
No.  
of institutions
No. 
 of cases
Performance rate of core measure (%)
Total
Tertiary 
hospital 
General 
hospital
Hospital
CAP 1 Oxygenation assessment 523 15,432 68.1 99.5 81.9 33.0 
CAP 2 Pneumonia severity assessment 523 15,432 56.3 98.4 72.2 13.8 
CAP 3 Sputum smears 523 15,432 68.1 98.6 77.1 41.8 
CAP 4 Sputum cultures 523 15,432 70.2 98.7 79.5 44.2 
CAP 5 Blood cultures prior to first intravenous  
antibiotics administration
336 8,533 85.2 95.1 84.4 72.1 
CAP 6 First dose of antibiotic within 8 hours 523 15,432 93.1 97.8 93.9 90.0 
CAP 7 Smoking cessation advice/counseling 138 1,101 92.2 100.0 92.7 63.0 
CAP 8 Screening for pneumococcal vaccination 469 8,632 53.7 99.7 66.5 15.8 
CAP: community-acquired pneumonia.
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within 24 hours of arrival at hospital was 68.1% (tertiary hospi-
tals, 98.6%; general hospitals, 77.1%; hospitals, 41.8%) (Figure 
3). This performance rate had a minimum of 0% and a maxi-
mum of 100%. The performance rate for sputum smears was 
low with a large variation among hospitals (mean, 39.9%; Q1, 
12.5%; Q3, 60.9%).
4) CAP 4. Sputum culture within 24 hours of hospital 
arrival
The overall performance rate of sputum cultures performed 
within 24 hours of arrival was 70.2% (tertiary hospitals, 98.7%; 
general hospitals, 79.5%; hospitals, 44.2%) (Figure 4). This 
performance rate had a minimum of 0% and a maximum of 
100%. The performance rate for sputum cultures was low with 
a large variation among hospitals (mean, 42.0%; Q1, 15.4%; Q3, 
64.3%).
5) CAP 5. Blood culture prior to first intravenous anti-
biotic administration 
Blood cultures taken prior to the initial administration of 
antibiotics accounted for 85.2% of all of the blood cultures 
(tertiary hospitals, 95.1%; general hospitals, 84.4%; hospitals, 
72.1%) (Figure 5). This performance rate had a minimum of 
0% and a maximum of 100%. Hospitals had a relatively high 
performance rate of blood cultures taken prior to the initial 
administration of antibiotics (mean, 69.3%; Q1, 57.1%; Q3, 
90.9%).
6) CAP 6. First dose of antibiotics administered within 
8 hours of the time of hospital arrival
The percentage of CAP patients receiving their first dose of 
antibiotics within 8 hours of their arrival at hospital was 93.1%. 
Overall, this performance rate was the highest and had the 
least institutional variation (tertiary hospitals, 97.8%; general 
hospitals, 93.9%; hospitals, 90.0%) (Figure 6). This perfor-
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Figure 1. Performance rates of oxygenation assessment according to institution.
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Figure 2. Performance rates of pneumonia severity assessment according to institution.
Quality of care for CAP
https://doi.org/10.4046/trd.2017.0093 181www.e-trd.org
Total
100
80
60
40
20
P
e
rf
o
rm
a
n
c
e
ra
te
(%
)
Sputum smears
0
Tertiary
hospital
General
hospital
Hospital Total
100
80
60
40
20
D
is
tr
ib
u
ti
o
n
o
f
p
e
rf
o
rm
a
n
c
e
ra
te
Sputum smears
0
Tertiary
hospital
General
hospital
Hospital
Figure 3. Performance rates of sputum smears within 24 hours of hospital arrival according to institution.
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Figure 5. Performance rates of blood cultures taken prior to the initial administration of antibiotics according to institution.
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Figure 4. The performance rates of sputum cultures performed within 24 hours of hospital arrival according to institution.
JY Hong et al.
182 Tuberc Respir Dis 2018;81:175-186 www.e-trd.org
mance rate had a minimum of 0% and a maximum of 100%. 
Among hospitals, the performance rate was high with low 
variation (mean, 89.1%; Q1, 84.6%; Q3, 100.0%).
7) CAP 7. Smoking cessation counseling
The percentage of CAP patients with a history of smoking 
within a 1-year period who were offered smoking cessation 
counseling was 92.2%. This performance rate was lowest in 
hospitals (tertiary hospitals, 100.0%; general hospitals, 92.7%; 
hospitals, 63.0%) (Figure 7). The performance rate of smoking 
cessation counseling had a minimum of 0% and a maximum 
of 100%. There was a large variation in the performance rate 
among hospitals (mean, 68.5%; Q1, 36.7%; Q3, 100%).
8) CAP 8. Screening for pneumococcal vaccination
The performance rate of screening for pneumococcal vac-
cination in patients aged 65 years and older was 53.7%. This 
performance rate greatly varied depending on the type of 
institution (tertiary hospitals, 99.7%; general hospitals, 66.5%; 
hospitals, 15.8%). There was a large difference in the perfor-
mance rate between tertiary hospitals and hospitals (Figure 8). 
The performance rate of screening for pneumococcal vaccina-
tion had a minimum of 0% and a maximum of 100%. The per-
formance rate was lowest in hospitals (mean, 15.5%; Q1, 0.0%; 
Q3, 8.7%). However, general hospitals had a large variation in 
the performance rate (mean, 65.3%; Q1, 0.0%; Q3, 100.0%). A 
total of 189 institutions had a minimum measurement rate of 
zero (62 general hospitals and 127 hospitals). 
4. Hospital CAP monitoring measures
1) CAP 9. Median time from initial hospital arrival to 
the first dose of antibiotics
The median time from the initial arrival at hospital to the 
Figure 6. Performance rates of the administration of the first dose of antibiotics within 8 hours of the time of hospital arrival according to insti-
tution.
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Figure 7. Performance rates of smoking cessation counseling according to institution.
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administration of the first dose of antibiotics was 83 min (ter-
tiary hospitals, 175 minutes; general hospitals, 99 minutes; 
hospitals, 27 minutes) (Table 6). Fifty-nine institutions had a 
median value of less than zero (11 general hospitals and 48 
hospitals).
2) CAP 10. Selection of appropriate initial antibiotics
The rate of appropriate intravenous antibiotic administra-
tion according to the recommendation of the treatment guide-
line was 81.9% (Table 6). Tertiary hospitals had a high rate of 
appropriate intravenous antibiotic administration (tertiary 
hospitals, 92.7%; general hospitals, 84.6%; hospitals, 73.3%).
3) CAP 11. Duration of intravenous antibiotic adminis-
tration
The median duration of intravenous antibiotic administra-
tion for pneumonia was 8 days (Table 6). The duration of 
intravenous antibiotics in tertiary hospitals was lower by 1 day 
than that of general hospitals and hospitals.
4) CAP 12. Thirty-day readmission rate
The readmission rate within 30 days after pneumonia treat-
ment was 2.0% (tertiary hospitals, 1.1%; general hospitals, 2.3%; 
hospitals, 1.8%) (Table 6). While the readmission rate of pa-
tients discharged after being hospitalized via the emergency 
room was high in tertiary hospitals, the readmission rate of 
patients discharged after hospitalization via the outpatient de-
partment was high in general hospitals and hospitals. The 30-
day readmission rate was also high in subjects older than 70 
years. 
5) CAP 13. Thirty-day mortality rate
The mean 30-day mortality rate after admission was 3.7%. 
There was little difference between institutions in terms of 30-
day mortality after admission (tertiary hospitals, 3.8%; general 
hospitals, 3.6%; hospitals, 3.7%) (Table 6). The mean mortality 
rate was 3.8% and the median mortality rate was 1.9%. The 
mortality rates of patients admitted to the intensive care unit 
and subjects older than 70 years were high.
Table 6. The result of monitoring measures
Monitoring 
measure
Measure name
No. of 
institutions
No. of 
cases
Result
Total
Tertiary 
hospital 
General 
hospital
Hospital
Process Median time from initial hospital arrival  
to first dose of antibiotic, min  
520 15,240 83 175 99 27
Selection of appropriate initial antibiotics, % 523 15,432 81.9 92.7 84.6 73.3
Duration of intravenous antibiotic  
administration, day
523 15,272 8 7 8 8
Outcome 30-Day readmission rate, % 520 13,114 2.0 1.1 2.3 1.8 
30-Day mortality rate, % 523 14,974 3.7 3.8 3.6 3.7 
Figure 8. Performance rates of screening for pneumococcal vaccination according to institution.
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5. Composite measure score
The composite measure score was calculated in 482 insti-
tutions (92.2%) with more than 10 evaluation cases, among 
a total of 523 institutions. The mean composite measure 
score was 66.7 (tertiary hospitals, 98.5; general hospitals, 79.2; 
hospitals, 43.8). There was a large variation in the composite 
measure score among institutions, ranging from 15.1 to 100.0 
(Figure 9). The results of the quality measure set were publicly 
released for medical use and to allow data to be benchmarked 
by medical institutions. 
Discussion
Since the publication of process quality measures by Medi-
care in 2002 with the goal of improving health outcomes, 
the modification of these measures and the development of 
strategies to improve adherence have continued in the United 
States23,24. To the best of our knowledge, this is the first national 
report of care measures for CAP in Korea.
Eight core measures, a composite measure score reflecting 
the weighted value of each core measure, and five monitor-
ing measures regarding CAP were examined. An evidence 
link between hospital-based core measures and safety goals 
related to patient outcomes was found to exist25. Oxygenation 
assessment should be performed with pulse oximetry or arte-
rial blood gas because 10% of hypoxemic patients are asymp-
tomatic26. A arterial partial pressure of oxygen level of less than 
60 mm Hg, reflecting the severity of pneumonia, is associated 
with the 30-day mortality rate27. The guideline recommends 
that the CURB-65 criteria or the pneumonia severity index 
should be used as an objective criterion to determine whether 
or not patients require hospitalization and whether patients 
should be treated in the intensive care unit27.Microbiological 
testing such as sputum smears, sputum cultures, and blood 
cultures can lead to a change in antibiotic therapy in up to 40% 
of patients with severe pneumonia5. Timely administration of 
antibiotics is associated with a lower risk of mortality19. Smok-
ing cessation counseling is effective for ending smoking9. 
Smokers are at risk for severe pneumonia and are two to three 
times more likely to experience pneumonia than non-smok-
ers9. The pneumococcal vaccine is 40% effective for prevent-
ing pneumonia in high-risk patients10,11. Moreover, vaccination 
results in lower mortality and shorter hospitalization even 
in patients with pneumonia10,11. Monitoring measures such 
as the median time from the initial arrival at hospital to the 
administration of the first dose of antibiotics, the selection of 
appropriate initial antibiotics, and the duration of intravenous 
antibiotics are closely linked to the treatment effect26. 30-Day 
readmission rate, and 30-day mortality rate are other outcome 
measures. We assessed the overall performance rates of the 
quality measures and demonstrated the presence of variation 
among the performance rates across all measures. 
Our report showed that the performance rates of the core 
measures varied and that the variation among each type of in-
stitution was large. Remarkably, the performance rate in hos-
pitals was low and the variation within them was large, except 
for the performance rates of blood cultures taken prior to the 
first administration of antibiotics (72.1%) and the first dose of 
antibiotics administered within 8 hours of the time of hospital 
arrival (90%). Likewise, the composite measure score varied 
widely among the institutions (tertiary hospitals, 98.5; general 
hospitals, 79.2; hospitals, 43.8). There was a significant differ-
ence among the institutions in terms of the suitability of the 
initial selection of antibiotics (tertiary hospitals, 92.7%; general 
hospitals, 84.6%; hospitals, 73.3%) and the medical costs per 
case (tertiary hospitals, 2,410,000 Korean won; general hospi-
tals, 2,020,000 Korean won; hospitals, 1,340,000 Korean won). 
It is important that there are no significant differences in 30-
day mortality between hospitals, although there are significant 
differences in several measure scores and medical costs. The 
severity of pneumonia may offset the effect of quality of care 
in tertiary hospitals. The reasons for this are unclear and need 
further analysis. The development of appropriate quality mea-
surement tools that reflect the mortality is needed.
Previous studies monitored hospital performance and qual-
ity of care for single conditions over a specific period of time28-30. 
In the United States, a comprehensive analysis of the national 
trend in the Medicare core process measures for several dis-
eases was reported31. The report documented the success of 
process improvement among all United States hospitals in 
the Centers for Medicare and Medicaid Services (CMS) core 
process measures for acute myocardial infarction, heart fail-
ure, and pneumonia from 2006 to 201131. Efforts to improve 
the measurement of performance by numerous national 
initiatives yielded a reduction in hospital-level variability and 
generally high performance during that period32-34. CMS has 
steadily continued to add to, modify, and publicly report these 
Figure 9. Distribution of composite measure scores.
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care measures to maintain the accuracy and reliability of the 
measures for quality improvement24.
As national efforts focusing on quality improvement have 
continued in Korea, hospital performance in quality measures 
for several conditions has begun to be publicly reported. The 
first evaluation of the quality of care for hospitalized adult 
patients with CAP (from October to December 2014) was fol-
lowed by a secondary evaluation (from April to June 2016). 
Monitoring of the trend in performance measures over time 
should be continued because it is an important indicator of 
the success in achieving quality of care. Distinguishing and 
targeting lower-quality hospitals for quality improvement 
are expected to be beneficial in narrowing the gap between 
high-performing and low-performing hospitals. Modifying the 
existing measures and constructing novel ones is necessary to 
improve the accuracy and reliability of the measures for qual-
ity of care.
In conclusion, we documented the performance of care 
measures for CAP in 2014. We found diversity in the measures 
and large gaps among institutions in terms of performance of 
care measures. In particular, there was a lower level of perfor-
mance in hospitals compared to tertiary hospitals and general 
hospitals. Nonetheless, there were no significant differences 
in mortality between hospitals. Determining the appropriate 
care measures for CAP and monitoring the trend in perfor-
mance measures are needed.
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